Recent events
Recent events tied to this brand in public sources.
Back to profile6 entries
2022
NMD Pharma raises €35 million in financing
NMD Pharma announced that it had raised €35 million in a financing led by Jeito Capital, with investments from existing investors. The proceeds are intended to support clinical programs and expand its research and development pipeline.
2021
Aristea closes $63 million Series B financing
Aristea Therapeutics announced the closing of a $63 million Series B financing led by Fidelity Management & Research Company, with participation from existing investor Novo Holdings and new investors Arena Pharmaceuticals and funds managed by Tekla Capital Management.
2021
Muna Therapeutics closes US$73 million Series A financing
Muna Therapeutics announced that it had successfully closed a US$73 million Series A financing round. The round was co-led by Novo Holdings, Sofinnova Partners, Droia Ventures, and LSP Dementia Fund, with additional investors participating.
2021
Novo Holdings completes acquisition of BBI Group
Novo Holdings announced that it had acquired BBI Group from Exponent for an enterprise value of over GBP 400 million and would become its majority shareholder.
2021
Hummingbird Bioscience closes $125 million Series C financing
Hummingbird Bioscience announced that it closed a US$125 million Series C financing round led by Novo Holdings, with participation from new and existing investors.
2021
Deep Branch completes €8 million Series A round
Deep Branch announced that it had completed an €8 million Series A investment round led by Novo Holdings and DSM Venturing, with participation from Total Carbon Neutrality Ventures and Barclays Sustainable Impact Capital.